New method loads tumor cells with stimulants to boost cancer vaccines
Researchers used an ionic liquid cocktail to help tumor cells carry immunostimulatory cargo for better vaccine performance.
Scientists developed a way to load tumor cells with immunostimulatory CpG oligodeoxynucleotides. These loaded cells are called IL-Vax.
The process uses an ionic liquid-containing cocktail in a single step. This happens while tumor cells undergo immunogenic cell death.
Immunogenic cell death is a process occurring in tumor cells. CpG oligodeoxynucleotides are immunostimulatory cargos. Dendritic cells are cells that take up the vaccine.
IL-Vax improves how dendritic cells take up the vaccine and activate. This leads to potent antitumor immunity.
In a B16F10 melanoma mouse model, IL-Vax provided strong protection against tumor growth. It also worked with PD-1 blockade to slow tumor growth and extend survival.
The modularity of IL-Vax allows for loading different cargos or combinations. This may be useful for tailoring vaccines or other cell loading applications.
Key facts
- IL-Vax uses an ionic liquid-containing cocktail to load tumor cells.
- The method enhances dendritic cell uptake and activation.
- IL-Vax synergized with PD-1 blockade to extend survival in a therapeutic model.
- The system may allow for tailoring vaccines with different cargo combinations.